Company: SWAGW
Filing Date: 2025-03-07
Form Type: 10-Q
Source: 0001213900-25-021742
Chunk: 207

Company: Stran & Company, Inc.
Filing Date: 2025-03-07
Form: 10-Q
Item: Part I, Item 2
Chunk 207
---
 of
additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness would result in increased debt
service obligations and could require us to agree to operating and financial covenants that would restrict our operations. Financing may
not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to
us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.

40

Summary of Cash Flows

The following table provides detailed information about our net cash
flows for the nine months ended September 30, 2024 and 2023.

    Nine Months Ended  September 30, 

    2024 (in thousands)  
    2023 (Restated) (in thousands) 
  
    Net cash provided by (used in) operating activities 
    $1,427  
    $(1,598)
  
    Net cash provided by (used in) investing activities 
     1,516  
     (3,432)
  
    Net cash used in financing activities 
     (966) 
     (862)
  
    Net increase (decrease) in cash 
     1,977  
     (5,892)
  
    Cash and cash equivalents - beginning 
     8,059  
     15,254 
  
    Cash and cash equivalents - ending 
    $10,036  
    $9,362 

Net cash provided by operating activities was
approximately $1.4 million for the nine months ended September 30, 2024, as compared to net cash used in operating activities of approximately
$1.6 million for the nine months ended September 30, 2023. The change was primarily due to a decrease in accounts receivable.

Net cash provided by investing activities was
approximately $1.5 million for the nine months ended September 30, 2024, as compared to net cash used in investing activities of approximately
$3.4 million for the nine months ended September 30, 2023. The change was primarily due to increased proceeds from the sale of investments,
partially offset by increased purchases of investments.

Net cash used in financing activities was approximately
$1.0 million for the nine months ended September 30, 2024, as compared to approximately $0.9 million for the nine months ended